Shenyang Chemical Co., Ltd (SHE:000698)
China · Delayed Price · Currency is CNY 3.720
-0.090 (-2.36%)
Apr 3, 2026, 3:05 PM CST
Shenyang Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 5,611 | 4,962 | 5,233 | 5,311 | 9,875 |
Other Revenue | - | 58.14 | 48.75 | 630.03 | 256.57 |
| 5,611 | 5,020 | 5,282 | 5,941 | 10,132 | |
Revenue Growth (YoY) | 11.76% | -4.95% | -11.10% | -41.36% | 5.85% |
Cost of Revenue | 5,226 | 4,610 | 5,163 | 5,776 | 9,195 |
Gross Profit | 384.73 | 409.89 | 118.79 | 165.73 | 936.78 |
Selling, General & Admin | 165.54 | 280.35 | 228.47 | 194.75 | 186.64 |
Research & Development | 113.18 | 126.45 | 113.66 | 202.24 | 224.59 |
Other Operating Expenses | -14.16 | 4.46 | 45.33 | 359.7 | 70.03 |
Operating Expenses | 264.56 | 411.29 | 387.47 | 756.77 | 481.28 |
Operating Income | 120.17 | -1.4 | -268.69 | -591.04 | 455.5 |
Interest Expense | - | -63.87 | -88.24 | -124.43 | -136.94 |
Interest & Investment Income | - | 28.09 | 37.65 | 51.68 | 52.22 |
Currency Exchange Gain (Loss) | - | 3.15 | 1.24 | 1.33 | -0.89 |
Other Non Operating Income (Expenses) | -43.21 | -6.4 | -36.34 | -8.56 | -10.23 |
EBT Excluding Unusual Items | 76.96 | -40.44 | -354.38 | -671.03 | 359.65 |
Gain (Loss) on Sale of Investments | - | -93.25 | - | - | - |
Gain (Loss) on Sale of Assets | -23.58 | -38.03 | -44.62 | 0.51 | 3.47 |
Asset Writedown | -40.36 | -23.21 | -53.09 | -1,046 | -165.98 |
Other Unusual Items | - | 14.62 | 10.92 | 10.83 | 13.61 |
Pretax Income | 13.02 | -180.31 | -441.16 | -1,705 | 210.74 |
Income Tax Expense | 23.93 | -13.02 | 16.26 | 11.61 | 103.75 |
Earnings From Continuing Operations | -10.91 | -167.29 | -457.42 | -1,717 | 107 |
Minority Interest in Earnings | - | -0.74 | -0.83 | -0.74 | -0.98 |
Net Income | -10.91 | -168.03 | -458.24 | -1,718 | 106.01 |
Net Income to Common | -10.91 | -168.03 | -458.24 | -1,718 | 106.01 |
Net Income Growth | - | - | - | - | -70.34% |
Shares Outstanding (Basic) | 839 | 800 | 818 | 818 | 820 |
Shares Outstanding (Diluted) | 839 | 800 | 818 | 818 | 820 |
Shares Change (YoY) | 4.91% | -2.22% | 0.04% | -0.19% | - |
EPS (Basic) | -0.01 | -0.21 | -0.56 | -2.10 | 0.13 |
EPS (Diluted) | -0.01 | -0.21 | -0.56 | -2.10 | 0.13 |
EPS Growth | - | - | - | - | -70.34% |
Free Cash Flow | -62.54 | -266.76 | -175.42 | 569.55 | 1,256 |
Free Cash Flow Per Share | -0.07 | -0.33 | -0.21 | 0.70 | 1.53 |
Gross Margin | 6.86% | 8.16% | 2.25% | 2.79% | 9.25% |
Operating Margin | 2.14% | -0.03% | -5.09% | -9.95% | 4.50% |
Profit Margin | -0.19% | -3.35% | -8.68% | -28.91% | 1.05% |
Free Cash Flow Margin | -1.11% | -5.31% | -3.32% | 9.59% | 12.40% |
EBITDA | 345.21 | 213.56 | -39.32 | -143.5 | 949.51 |
EBITDA Margin | 6.15% | 4.25% | -0.74% | -2.42% | 9.37% |
D&A For EBITDA | 225.05 | 214.96 | 229.37 | 447.54 | 494.01 |
EBIT | 120.17 | -1.4 | -268.69 | -591.04 | 455.5 |
EBIT Margin | 2.14% | -0.03% | -5.09% | -9.95% | 4.50% |
Effective Tax Rate | 183.82% | - | - | - | 49.23% |
Revenue as Reported | - | - | - | 5,941 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.